SASo Woon Ahn

So Woon Ahn

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


So Woon Ahn has a total of 75 co-authors. Here are the top co-authors by number of shared publications:

  • Jong Chan Kim

    CHA Bundang Medical Center, CHA University

    6 shared publications
  • Hayeon Kwak

    CHA Bundang Medical Center, CHA University

    4 shared publications
  • Jihee Kim

    CHA Bundang Medical Center, CHA University

    4 shared publications
  • Chunghyun Park

    Department of Anesthesiology and Pain Medicine, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam-si, Republic of Korea

    3 shared publications
  • Jong Chan Kim

    Department of Anesthesiology and Pain Medicine, CHA Bundang Medical Center, CHA University, 59 Yatap-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 13496, South Korea

    3 shared publications
  • Young Keun Chae

    Department of Anesthesiology and Pain Medicine, Myoungji Hospital, Goyang, Korea

    3 shared publications

Latest Publications

  • Open Access

    Agreement between zero-heat-flux and tympanic thermometry in preschool children undergoing tonsillectomy: a prospective observational study

    by Chunghyun Park, Kunhyung Yang, Heejae So, So Woon Ahn

    Background: Continuous core temperature monitoring helps prevent perioperative complications in preschool children, but available noninvasive methods have important limitations. Zero-heat-flux (ZHF) thermometry is an alternative; however, evidence remains limited in preschool children during the developmental period of frontal sinus pneumatization. This study evaluated the clinical agreement of ZHF thermometry (TSpotOn) against tympanic temperature (Ttymp) in this developmental cohort. Methods: We conducted a prospective observational study of 154 preschoolers undergoing tonsillectomy. Intraoperative temperatures were recorded at 5-min intervals using ZHF, tympanic, and axillary (Taxilla) methods, for 1468 paired measurements in total. Agreement was assessed using repeated-measures Bland–Altman analysis, and within-participant association was evaluated using repeated-measures correlation. A ±0.5 °C difference was prespecified as an agreement criterion. Results: TSpotOn agreed closely with Ttymp, the repeated-measures correlation was strong ( r = 0.753, 95% CI 0.729–0.776; P < 0.001), and the mean bias was 0.06 °C. The 95% limits of agreement (− 0.35 °C to 0.47 °C) fell within the predefined ±0.5 °C agreement criterion. Taxilla, in contrast, showed a systematic underestimation (mean bias: −0.50 °C) with wider limits of agreement (− 1.09 °C to 0.09 °C) that exceeded this threshold. Conclusions: ZHF thermometry showed close agreement with tympanic thermometry while providing continuous, noninvasive temperature monitoring in preschool children within the expected developmental period of frontal sinus pneumatization. Given its closer agreement with tympanic thermometry than axillary monitoring, ZHF thermometry may be a practical option for continuous perioperative temperature monitoring in preschool children.

  • Non-Axillary Chest Skin Temperature Underestimates Core Temperature During Redistribution Hypothermia Following Spinal Anesthesia

    by Bo-Hyun Sang, Soojeong Oh, Lime Kim, So Woon Ahn

    Accurate temperature monitoring is essential for detecting perioperative hypothermia during spinal anesthesia, where rapid redistribution of body heat commonly occurs. Although zero-heat-flux (ZHF) thermometry has emerged as a noninvasive method for estimating core temperature, the reliability of chest skin temperature monitoring in this context remains unclear. In this prospective observational study, temperature measurements were obtained at 5-minute intervals using a forehead ZHF sensor, an infrared tympanic thermometer, and a non-axillary chest skin probe in patients undergoing orthopedic surgery under spinal anesthesia. Agreement between methods was evaluated using Bland—Altman analysis for repeated measurements, the proportion of paired measurements within ±0.5°C, and Lin’s concordance correlation coefficient. Ninety-nine patients completed the study. ZHF and tympanic temperatures showed good agreement, with a mean difference of 0.04 ± 0.35°C, limits of agreement from −0.63°C to 0.72°C, and 89% of paired measurements within ±0.5°C. In contrast, chest skin temperature demonstrated poor agreement with both ZHF and tympanic measurements. The mean difference between ZHF and chest skin temperature was 0.99 ± 1.11°C, with wide limits of agreement (−1.18°C to 3.17°C), and no measurements met the predefined ±0.5°C threshold. Similar discrepancies were observed when chest skin temperature was compared directly with tympanic temperature. These findings indicate that non-axillary chest skin temperature does not reliably reflect core temperature during redistribution hypothermia under spinal anesthesia and should not be used as a surrogate. ZHF thermometry showed substantially better agreement with tympanic temperature and may provide a more reliable noninvasive alternative for perioperative temperature monitoring.

  • Open Access

    Comparison of core temperature monitoring methods during cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a prospective observational study

    by Jung-Won Kim, Jin Ho Kim, Soojeong Oh, So Woon Ahn

    During cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC), precise core temperature monitoring is critical for patient safety. This prospective study evaluated the agreement among three core temperature monitoring modalities: nasopharyngeal temperature (Tnaso), zero-heat flux cutaneous thermometer (TSpotOn), and oesophageal temperature (Teso). Temperatures were measured simultaneously; agreement between monitoring sites was assessed using Bland–Altman analysis for repeated measures including mean bias, 95% limits of agreement, and confidence intervals, alongside Lin’s concordance correlation coefficient (LCCC). The proportion of paired differences within the clinically acceptable limit of 0.5 °C was reported. The mean difference between Tnaso and TSpotOn was −0.04 ± 0.33 °C (95% limits: −0.69 to 0.62), and between Tnaso and Teso was 0.02 ± 0.35 °C (95% limits: −0.66 to 0.71), with LCCC for both comparisons at 0.94 (95% CI: 0.93–0.94), indicating substantial agreement. However, up to 14% of Teso pairs exceeded the 0.5 °C threshold, suggesting potential clinical relevance. Notable rapid temperature decline and subsequent rebound were observed post-HIPEC at Tnaso and TSpotOn sites. All three monitoring methods correlated strongly overall, but Teso exhibited phase-dependent discrepancies, particularly after HIPEC. These findings support tailoring core temperature measurement site selection with attention to the target organ, especially in laparotomy-based HIPEC procedures. Trial registration: The study was registered in the clinical trials registry cris.nih.go.kr (Registration Number: KCT0003980).


  • Open Access

    A comparison of core temperature at different sites during cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: A prospective observational study

    by Jung–Won Kim, Jin Ho Kim, Soojeong Oh, So Woon Ahn

    Background: During cytoreductive surgery with hyperthermic intraperitoneal chemotherapy, body temperature rapidly changes due to the hyperthermic agent. Depending on the method used, obtained values may vary, particularly during localized heating of the abdominal cavity. The primary aim of our study was to compare the effectiveness of core temperature monitoring techniques, nasopharyngeal temperature, zero-heat flux cutaneous thermometer device, and esophageal temperature, during hyperthermic intraperitoneal chemotherapy with cytoreductive surgery. Methods: Body temperature was measured using a zero-heat flux cutaneous thermometer device on the forehead and esophageal and nasopharyngeal probes throughout the surgery. Temperature differences were then calculated for each pair of measurements. We conducted an agreement analysis between the nasopharyngeal temperature and reference core temperature measurements using the 95% Bland–Altman limits of agreement for repeated measurement data. The proportion of all differences that were within 0.5 °C and repeated measures Lin’s concordance correlation coefficient were estimated. Results: The mean overall difference between nasopharyngeal and forehead temperature was -0.04 ± 0.33 °C (95% limits of agreement: -0.69–0.62), and esophageal temperature was 0.02 ± 0.35°C (95% limits of agreement: -0.66–0.71). The proportion of differences within 0.5 °C of TSpotOn was 0.03 (95% CI 0.01–0.04) and that of esophageal temperature was -0.06 (95% CI -0.08 to -0.05). The Lin’s concordance correlation coefficient of both were 0.94 (95% CI 0.93–0.94). After the hyperthermic intraperitoneal chemotherapy period, the temperatures rapidly decreased, followed by a noticeable rebound increase, particularly nasopharyngeal and forehead temperatures. The maximum difference between esophageal temperature and other temperatures was 1.5 °C. Conclusions: Our results reveal a strong correlation between nasopharyngeal, zero-heat flux cutaneous, and esophageal temperatures during surgery. However, consistent temperature differences with the esophageal thermometer were not observed. Post-hyperthermic intraperitoneal chemotherapy, rebound heating occurred at all sites, notably in the nasopharyngeal and zero-heat flux cutaneous areas.

  • Open Access

    Improvement in cerebral oxygen saturation with sinus conversion during off pump coronary artery bypass graft: A case report

    by He Won Hwang, Jin Ho Kim, So Woon Ahn

    Rationale: Near-infrared spectroscopy (NIRS) is a noninvasive bedside tool for monitoring regional cerebral oxygen saturation (rSO2). The sinus conversion of atrial fibrillation (AF) was shown to be responsible for increasing rSO2. However, the reason for this improvement has not yet been clearly explained. Patient concerns: We report the case of a 73-year-old woman who underwent cardioversion during an off-pump coronary artery bypass under NIRS and live hemodynamic monitoring. Interventions: Unlike previous studies that failed to control and compare all conditions during procedures, this case showed real-time fluctuating hemodynamic and hematological values, such as hemoglobin (Hgb), central venous pressure (CVP), mean arterial pressure (MAP), cardiac index (CI), left ventricular end-diastolic pressure (LVEDP), and SVO2. Outcomes: The rSO2 increased immediately after cardioversion and decreased during the obtuse marginal (OM) graft and after AF was obtained. However, no other hemodynamic data showed the same or opposite directional changes in the rSO2. Lessons: Significant instantaneous changes were observed in rSO2 using NIRS after sinus conversion, without obvious hemodynamic alterations in the systemic circulation or other monitoring values.


  • Open Access

    Premedication with dexmedetomidine to reduce emergence agitation: a randomized controlled trial

    by Jong Chan Kim, Jihee Kim, Hayeon Kwak, So Woon Ahn

    Background: Nasal bone fracture is the most common type of facial fracture, and the high incidence of severe emergence agitation occurring after closed reduction of the nasal bone fracture can be challenging to manage. The purpose of this trial was to evaluate whether pre-operative administration of dexmedetomidine is effective in reducing the incidence and severity of emergence agitation in adults undergoing closed reduction of nasal bone fractures. Methods: In this randomized controlled trial, 90 patients who were scheduled to undergo closed reduction of a nasal bone fracture were prospectively included and were randomly assigned to either the control group (n = 45; 0.9% saline infusion) or the dexmedetomidine group (n = 45; 1 μ/kg over 10 min, pre-operatively). The primary endpoint was Aono's four-point scale scores after anesthesia. The recovery time and numeric rating scale score were assessed as secondary endpoints. Results: Aono's four-point scale scores were lower in the dexmedetomidine group than in the control group (median: 1 [1-1] vs. 1 [1-2], 95% confidence interval of difference: 0.01 to 0.02, P = 0.02). The number, severity, and duration of agitation episodes were significantly lower in the dexmedetomidine group than in the control group. Furthermore, the number of patients exhibiting intraoperative movement was lower in the dexmedetomidine group. Conclusions: Pre-operative administration of dexmedetomidine demonstrated several significant benefits, such as a lower incidence of emergence agitation, reduced agitation severity, and a shorter duration of agitation. Additionally, we observed more stable maintenance of intraoperative anesthesia with less movement during the surgery.

  • Open Access

    Premedication with dexmedetomidine to reduce emergence agitation: a randomized controlled trial

    by Jong Chan Kim, Jihee Kim, Hayeon Kwak, So Woon Ahn

    Nasal bone fracture is the most common type of facial fracture, and the high incidence of severe emergence agitation occurring after closed reduction of the nasal bone fracture can be challenging to manage. The purpose of this trial was to evaluate whether pre-operative administration of dexmedetomidine is effective in reducing the incidence and severity of emergence agitation in adults undergoing closed reduction of nasal bone fractures. In this randomized controlled trial, 90 patients who were scheduled to undergo closed reduction of a nasal bone fracture were prospectively included and were randomly assigned to either the control group (n = 45; 0.9% saline infusion) or the dexmedetomidine group (n = 45; 1 μ/kg over 10 min, pre-operatively). The primary endpoint was Aono’s four-point scale scores after anesthesia. The recovery time and numeric rating scale score were assessed as secondary endpoints. Aono’s four-point scale scores were lower in the dexmedetomidine group than in the control group (median: 1 [1] vs. 1 [1, 2], 95% confidence interval of difference: 0.01 to 0.02, P = 0.02). The number, severity, and duration of agitation episodes were significantly lower in the dexmedetomidine group than in the control group. Furthermore, the number of patients exhibiting intraoperative movement was lower in the dexmedetomidine group. Pre-operative administration of dexmedetomidine demonstrated several significant benefits, such as a lower incidence of emergence agitation, reduced agitation severity, and a shorter duration of agitation. Additionally, we observed more stable maintenance of intraoperative anesthesia with less movement during the surgery. Identifier: KCT0000585 (registration date: 12–19- 2012).


  • Open Access

    Premedication with dexmedetomidine to reduce emergence agitation: a randomized controlled trial

    by Jong Chan Kim, Jihee Kim, Hayeon Kwak, So Woon Ahn

    Background: Nasal bone fracture is the most common type of facial fracture, and the high incidence of severe emergence agitation occurring after closed reduction of the nasal bone fracture can be challenging to manage. The purpose of this trial was to evaluate whether pre-operative administration of dexmedetomidine is effective in reducing the incidence and severity of emergence agitation in adults undergoing closed reduction of nasal bone fractures. Methods: In this randomized controlled trial, 90 patients who were scheduled to undergo closed reduction of a nasal bone fracture were prospectively included and were randomly assigned to either the control group (n = 45; 0.9% saline infusion) or the dexmedetomidine group (n = 45; 1 μ/kg over 10 min, pre-operatively). The primary endpoint was Aono's four-point scale scores after anesthesia. The recovery time and numeric rating scale score were assessed as secondary endpoints. Results: Aono's four-point scale scores were lower in the dexmedetomidine group than in the control group (median: 1 [1-1] vs. 1 [1-2], 95% confidence interval of difference: 0.01 to 0.02, P = 0.02). The number, severity, and duration of agitation episodes were significantly lower in the dexmedetomidine group than in the control group. Furthermore, the number of patients exhibiting intraoperative movement was lower in the dexmedetomidine group. Conclusions: Pre-operative administration of dexmedetomidine demonstrated several significant benefits, such as a lower incidence of emergence agitation, reduced agitation severity, and a shorter duration of agitation. Additionally, we observed more stable maintenance of intraoperative anesthesia with less movement during the surgery.

  • Open Access

    Premedication with dexmedetomidine to reduce emergence agitation: a randomized controlled trial

    by Jong Chan Kim, Jihee Kim, Hayeon Kwak, So Woon Ahn

    Background: Nasal bone fracture is the most common type of facial fracture, and the high incidence of severe emergence agitation occurring after closed reduction of the nasal bone fracture can be challenging to manage. The purpose of this trial was to evaluate whether pre-operative administration of dexmedetomidine is effective in reducing the incidence and severity of emergence agitation in adults undergoing closed reduction of nasal bone fractures. Methods: In this randomized controlled trial, 90 patients who were scheduled to undergo closed reduction of a nasal bone fracture were prospectively included and were randomly assigned to either the control group (n = 45; 0.9% saline infusion) or the dexmedetomidine group (n = 45; 1 mcg/kg over 10 minutes, pre-operatively). The primary endpoint was Aono's four-point scale after anesthesia. The recovery time and numeric rating scale score were assessed as secondary endpoints. Results: Aono's four-point scale scores were lower in the dexmedetomidine group than in the control group (median: 1 [1-1] vs. 1 [1-2], 95% comfidence interval of difference: 0.01 to 0.02, P = 0.02). The number, severity, and duration of agitation episodes were significantly lower in the dexmedetomidine group than in the control group. Furthermore, the number of patients exhibiting intraoperative movement was lower in the dexmedetomidine group. Conclusions: Pre-operative administration of dexmedetomidine demonstrated several significant benefits, such as a lower incidence of emergence agitation, reduced agitation severity, and a shorter duration of agitation. Additionally, we observed more stable maintenance of intraoperative anesthesia with less movement during the surgery.

  • Open Access

    Premedication with dexmedetomidine to reduce emergence agitation: a randomized controlled trial

    by Jong Chan Kim, Jihee Kim, Hayeon Kwak, So Woon Ahn

    Background Nasal bone fracture is the most common type of facial fracture, and the high incidence of severe emergence agitation occurring after closed reduction of the nasal bone fracture can be challenging to manage. The purpose of this trial was to evaluate whether pre-operative administration of dexmedetomidine is effective in reducing the incidence and severity of emergence agitation in adults undergoing closed reduction of nasal bone fractures. Methods In this randomized controlled trial, 90 patients who were scheduled to undergo closed reduction of a nasal bone fracture were prospectively included and were randomly assigned to either the control group (n = 45; 0.9% saline infusion) or the dexmedetomidine group (n = 45; 1 mcg/kg over 10 minutes, pre-operatively). The primary endpoint was Aono's four-point scale after anesthesia. The recovery time and numeric rating scale score were assessed as secondary endpoints. Results Aono's four-point scale scores were lower in the dexmedetomidine group than in the control group [median (IQR); 1 (1-1) vs. 1 (1-2), 95% CI of difference; 0.01 to 0.02, P = 0.02]. The number, severity, and duration of agitation episodes were significantly lower in the dexmedetomidine group than in the control group. Furthermore, the number of patients exhibiting intraoperative movement was lower in the dexmedetomidine group. Conclusions Pre-operative administration of dexmedetomidine demonstrated several significant benefits, such as a lower incidence of emergence agitation, reduced agitation severity, and a shorter duration of agitation. Additionally, we observed more stable maintenance of intraoperative anesthesia with less movement during the surgery.